{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:23:01Z","timestamp":1768465381413,"version":"3.49.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>An involvement of selective serotonin reuptake inhibitors (SSRIs) in increasing the risk of malformations, neonatal withdrawal syndrome, has been suggested recently. Here, we aimed to investigate the contribution of individual pharmacogenetics of SSRI on infants' outcome. We also estimated the umbilical\/maternal plasma SSRI concentration ratio in the pregnant women still on SSRI therapy at the time of delivery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Thirty-four pregnant women, referred to our hospital from January 2011 to July 2015, who were given SSRIs in the third trimester, and related children, were considered. The umbilical\/maternal plasma SSRI concentration ratio was estimated in 15 mothers still on SSRI therapy at the time of delivery. For patients with pharmacokinetic analyses, blood samples were collected for pharmacogenetic analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Nineteen newborns presented clinical signs possibly related to drug toxicity. A high umbilical\/maternal plasma ratio of SSRI was observed in 10 of the 15 evaluated newborns. Five mothers were intermediate metabolizers and 1 a poor metabolizer for the major CYP enzyme involved in pharmacokinetic pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Individualized psychopharmacologic treatment that takes into account the mother's exposure to SSRI concentrations and eventually her genetic background may become the standard of care to maximize drug benefit and minimize risks to the newborn.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000370","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T13:54:23Z","timestamp":1483106063000},"page":"197-201","source":"Crossref","is-referenced-by-count":21,"title":["Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy: An Observational Study"],"prefix":"10.1097","volume":"39","author":[{"given":"Laura","family":"Pogliani","sequence":"first","affiliation":[{"name":"Department of Pediatrics, ASST Fatebenefratelli-Sacco, L. Sacco University Hospital, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia S.","family":"Falvella","sequence":"additional","affiliation":[{"name":"Unit of Clinical Pharmacology, ASST Fatebenefratelli-Sacco, L. Sacco University Hospital, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"Unit of Clinical Pharmacology, ASST Fatebenefratelli-Sacco, L. Sacco University Hospital, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Pileri","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, ASST Fatebenefratelli-Sacco, L. Sacco Hospital, University Hospital, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna F.","family":"Moscatiello","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, ASST Fatebenefratelli-Sacco, L. Sacco University Hospital, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Cheli","sequence":"additional","affiliation":[{"name":"Unit of Clinical Pharmacology, ASST Fatebenefratelli-Sacco, L. Sacco University Hospital, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Baldelli","sequence":"additional","affiliation":[{"name":"Unit of Clinical Pharmacology, ASST Fatebenefratelli-Sacco, L. Sacco University Hospital, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Fabiano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, ASST Fatebenefratelli-Sacco, Ospedale dei Bambini V. Buzzi, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Cetin","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, ASST Fatebenefratelli-Sacco, L. Sacco Hospital, University Hospital, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, Consiglio Nazionale delle Ricerche Institute of Neuroscience, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Universit\u00e0 degli Studi di Milano, Milan; and"},{"name":"E. Medea Scientific Institute, Bosisio Parini, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianvincenzo","family":"Zuccotti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, ASST Fatebenefratelli-Sacco, L. Sacco University Hospital, Milan;"},{"name":"Department of Pediatrics, ASST Fatebenefratelli-Sacco, Ospedale dei Bambini V. Buzzi, Milan;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/jwh.2013.4438","article-title":"Postpartum anxiety and comorbid depression in a population-based sample of women","volume":"23","author":"Farr","year":"2014","journal-title":"J Womens Health (Larchmt)."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/j.semperi.2015.08.010","article-title":"SSRI use during pregnancy","volume":"39","author":"Tran","year":"2015","journal-title":"Semin Perinatol."},{"key":"R3-20230814","article-title":"Screening for neonatal depression","year":"2015","journal-title":"Am Coll Obstetrician Gynecologist."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"Cooper","year":"2007","journal-title":"Am J Obstet Gynecol."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2007.07.036","article-title":"Use of antidepressant medications during pregnancy: a multisite study","volume":"198","author":"Andrade","year":"2008","journal-title":"Am J Obstet Gynecol."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2007.03048.x","article-title":"Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands","volume":"65","author":"Bakker","year":"2008","journal-title":"Br J Clin Pharmacol."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CLEP.S9256","article-title":"Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis","volume":"2","author":"Kornum","year":"2010","journal-title":"Clin Epidemiol."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00023210-200923060-00004","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy","volume":"23","author":"Alwan","year":"2009","journal-title":"CNS Drugs."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/JCP.0b013e3181bf344c","article-title":"Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction","volume":"29","author":"Toh","year":"2009","journal-title":"J Clin Psychopharmacol."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"f6932","DOI":"10.1136\/bmj.f6932","article-title":"Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis","volume":"348","author":"Grigoriadis","year":"2014","journal-title":"BMJ"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/apa.12921","article-title":"Risk factors for poor neonatal adaptation after exposure to antidepressants in utero","volume":"104","author":"Kieviet","year":"2015","journal-title":"Acta Paediatr."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.4088\/JCP.12r07967","article-title":"The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J Clin Psychiatry."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bpobgyn.2015.04.004","article-title":"Depression during pregnancy","volume":"29","author":"Pearlstein","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","article-title":"The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month","volume":"173","author":"Salisbury","year":"2016","journal-title":"Am J Psychiatry."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1176\/appi.ajp.2015.14121575","article-title":"Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data","volume":"172","author":"Malm","year":"2015","journal-title":"Am J Psychiatry."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cpt.147","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors","volume":"98","author":"Hicks","year":"2015","journal-title":"Clin Pharmacol Ther."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2217\/pgs.13.181","article-title":"CYP2D6 -1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers","volume":"14","author":"Llerena","year":"2013","journal-title":"Pharmacogenomics"},{"key":"R20-20230814","first-page":"528","article-title":"Development of a LC-MS\/MS method for therapeutic drug monitoring of antidepressants and antipsychotics in human plasma","volume":"33","author":"Baldelli","year":"2011","journal-title":"Ther Drug Monit."},{"key":"R22-20230814","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111327","article-title":"Neonatal adaptation in infants prenatally exposed to antidepressants\u2014clinical monitoring using Neonatal Abstinence Score","volume":"9","author":"Forsberg","year":"2014","journal-title":"PLoS One"},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","article-title":"The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month","volume":"173","author":"Salisbury","year":"2016","journal-title":"Am J Psychiatry."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"276918","DOI":"10.1155\/2014\/276918","article-title":"Serotonin reuptake inhibitors in pregnancy: can genes help us in predicting neonatal adverse outcome?","volume":"2014","author":"Giudici","year":"2014","journal-title":"Biomed Res Int."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201704000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:05:34Z","timestamp":1692050734000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201704000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000370","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}